Dr. Nimer has been researching the AML1-ETO protein at MSKCC since 1993. He and his colleagues first demonstrated in 1995 that AML1-ETO functions as a transcriptional repressor and dominantly inhibits AML1 function.
'/>"/>
| Contact: Esther Napolitano napolite@mskcc.org 212-639-3139 Memorial Sloan-Kettering Cancer Center Source:Eurekalert |